Article info
PDFResearch
Original article
Belgian cost-effectiveness analysis of hydroxocobalamin (Cyanokit) in known or suspected cyanide poisoning
- Correspondence to Severien Drieskens, Panacea Officinalis BVBA, Meir 80, Antwerp 2000, Belgium; s.drieskens{at}panacea-consulting.eu
Citation
Belgian cost-effectiveness analysis of hydroxocobalamin (Cyanokit) in known or suspected cyanide poisoning
Publication history
- Received August 24, 2012
- Revised December 10, 2012
- Accepted January 3, 2013
- First published January 29, 2013.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions